omniture
logo
Search
Samsung Biologics Co. Ltd.
Media Room

Latest News

rss

Samsung Biologics Issues Its First Annual Sustainability Report

* Consolidation of the company's roadmap to creating an improved business environment * Establi...

2021-06-25 09:01 22554
Samsung Biologics Issues Its First Annual Sustainability Report

Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

* Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessm...

2021-06-23 19:28 1374
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

INCHEON, South Korea, June 2, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's ...

2021-06-02 19:00 1422
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

* Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its...

2021-05-31 19:00 2253
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services

Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management

* Expanding upon its existing ISO22301 certification, Samsung Biologics is now fully certified wi...

2021-05-28 20:00 2740
Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

CAMBRIDGE, Mass. and INCHEON, South Korea, May 22, 2021 /PRNewswire/ -- Moderna (Nasdaq: MRNA), a b...

2021-05-23 00:00 8900
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine

Samsung Biologics Reports First Quarter 2021 Financial Results

* Q1'21 revenue of KRW 260.8 billion increased 26% compared to Q1'20. * Q1'21 operating profit o...

2021-04-28 16:37 4491

Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."

INCHEON, South Korea, April 21, 2021 /PRNewswire/ -- Samsung Biologics, the world's leading contrac...

2021-04-21 19:00 1568
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission,

Samsung Biologics Unveils Strong Performance and Future Plans at its 10th Annual General Meeting of Shareholders

INCHEON, South Korea, March 18, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced a...

2021-03-19 09:49 4852
Samsung Biologics Unveils Strong Performance and Future Plans at its 10th Annual General Meeting of Shareholders

Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced an...

2021-01-27 08:26 6107

Samsung Biologics Reports 66% Increase in 2020 Revenue Achieving "1 Trillion Won" Target Sales

INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) reported its...

2021-01-26 15:00 6207

Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference

INCHEON, South Korea, Jan. 13, 2021 /PRNewswire/ -- Samsung Biologics (207940.KS) set forth its dyn...

2021-01-13 23:17 7491
Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference

Samsung Biologics Names John Rim as President and CEO

INCHEON, South Korea, Dec. 16, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announcedJoh...

2020-12-16 20:00 1441
Samsung Biologics Names John Rim as President and CEO

Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch

INCHEON, South Korea, Dec. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced the...

2020-12-04 20:00 2324
Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch

Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility

INCHEON, South Korea, Nov. 18, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) officially b...

2020-11-18 20:00 1776
Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility

Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

INDIANAPOLIS and INCHEON, South Korea, Nov. 17, 2020 /PRNewswire/ -- Samsung Biologics' partnership...

2020-11-17 20:00 1573
Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation

INCHEON, South Korea, Oct. 4, 2020 /PRNewswire/ -- Samsung Biologics' Virtual Exhibition Hall was r...

2020-11-04 20:00 1764

Samsung Biologics Establishes Partnership with China Biotech GeneQuantum Healthcare to Collaborate on ADC Development

INCHEON, South Korea and SUZHOU, China, Nov. 1, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) ...

2020-11-02 08:27 1400

Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center

INCHEON, South Korea and SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- At a virtual ceremony today, ...

2020-10-29 08:38 6608

Samsung Biologics' strategic business operations continue to support strong third quarter earnings

INCHEON, South Korea, Oct. 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) maintained s...

2020-10-21 19:00 8173
12345